ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers

This study is currently recruiting participants.
Verified by The University of Texas Health Science Center at San Antonio, December 2007

Sponsors and Collaborators: The University of Texas Health Science Center at San Antonio
Department of Veterans Affairs
Information provided by: The University of Texas Health Science Center at San Antonio
ClinicalTrials.gov Identifier: NCT00223483
  Purpose

This research study goal is to analyze the plasma and the cells that make up part of the immune system. We want to learn how the plasma and cells work. These may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while others remain without symptoms.


Condition Intervention
Hematologic Diseases
Healthy Volunteers
Genetic: Isolation of genomic DNA

U.S. FDA Resources

Study Type:   Observational
Study Design:   Other, Prospective
Official Title:   Identification and Analysis of Immunomodulatory Molecules From Leukocytes in Patients With Hematologic Disorders and Healthy Volunteers

Further study details as provided by The University of Texas Health Science Center at San Antonio:

Biospecimen Retention:   Samples With DNA

Biospecimen Description:

Whole blood, serum, white cells


Estimated Enrollment:   1000
Study Start Date:   March 2005
Estimated Study Completion Date:   March 2015

Intervention Details:
    Genetic: Isolation of genomic DNA
    One time blood draw
Detailed Description:

This research study goal is to analyze the plasma and the cells that make up part of the immune system. These cells, called white cells or leukocytes, are present in blood. We want to learn how these cells work to prevent infection and how they respond after an infection occurs. We also want to study certain molecules present on the plasma, on or in these cells, and the genetic material that allows these molecules to be made. These molecules may influence why one person will develop an infection and another will not, or why one person develops severe symptoms of a disease while others remain without symptoms. This study may increase our understanding of a variety of diseases including infections such as HIV, allergic diseases such as asthma, joint diseases such as rheumatoid arthritis, certain cancers, and the rejection process that sometimes occurs after transplantation of an organ.

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample

Study Population

Primary care clinic and community samples


Criteria

Inclusion Criteria:

  • Must be able to give blood
  • Must be able to give informed consent
  • Signed, written informed consent

Exclusion Criteria:

  • Individuals with a history severe anemia, inadequate venous access, severe blood or coagulation disorders.
  • Pregnant women are excluded because it is a unique immunotolerant state and will alter the profile of immunomodulatory molecules.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00223483

Contacts
Contact: Juan J Toro, MD     210-617-5300 ext 16777     juantoro2@va.gov    

Locations
United States, Texas
The University of Texas Health Science Center at San Antonio     Recruiting
      San Antonio, Texas, United States, 78229
      Contact: Juan J Toro, MD     210-617-5300 ext 16777     juantoro2@va.gov    
      Principal Investigator: Juan J Toro, MD            
Department of Veterans Affairs, South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division     Recruiting
      San Antonio, Texas, United States, 78229
      Contact: Juan J Toro, MD     210-617-5300 ext 16777     juantoro2@va.gov    
      Principal Investigator: Juan J Toro, MD            
Cancer Therapy & Research Center     Recruiting
      San Antonio, Texas, United States, 78229
      Contact: Juan J Toro, MD     210-617-5300 ext 16777     juantoro2@va.gov    
      Principal Investigator: Juan J Toro, MD            

Sponsors and Collaborators
The University of Texas Health Science Center at San Antonio
Department of Veterans Affairs

Investigators
Study Director:     Cesar O Freytes, MD     The University of Texas Health Science Center at San Antonio    
  More Information


Responsible Party:   South Texas Veterans Health Care System ( Juan J. Toro )
Study ID Numbers:   HSC20040268H
First Received:   September 13, 2005
Last Updated:   December 15, 2007
ClinicalTrials.gov Identifier:   NCT00223483
Health Authority:   United States: Food and Drug Administration

Keywords provided by The University of Texas Health Science Center at San Antonio:
Hematologic Diseases  
Genomics  
Cytokines  
Chemokines  
Receptors  

Study placed in the following topic categories:
Hematologic Diseases
Healthy

ClinicalTrials.gov processed this record on October 03, 2008




Links to all studies - primarily for crawlers